Genesis AI Corp. (CSE: AIG) (OTCQB: AIGFF) (the "Company") is excited to announce the launch of Wildfire Defence Solutions Version 1.2, a powerful update to the wildfire management tool.

Gilead Sciences has struck a deal to work with privately held Genesis Therapeutics to use generative artificial intelligence to discover and develop novel, small-molecule therapies across multiple ...

There is speculation aplenty that OpenAI o1 new generative AI might be leveraging multiple chain-of-thought and ...

The AI craze has taken the market by storm, dominated by chipmaker Nvidia. Over the last three years, Nvidia stock has ...

Kelowna, British Columbia--(Newsfile Corp. - June 10, 2024) - Genesis AI Corp. (CSE: AIG) (OTCQB: AIGFF) (the "Company") is pleased to announce the release of their wildfire tool, Wildfire Defence ...

Yes, the massive influx of investments and sky-high evaluations are dropping, but the true AI Revolution is still in its genesis ... Chipmaker NVIDIA reached a $1 trillion market cap at the ...

Technical analysis for Genesis Energy L.p. GEL including support levels resistance levels and stop losses for GEL ...

Genesis Therapeutics specializes in AI-driven small molecule drug discovery ... The company's HIV prevention drug, lenacapavir, demonstrated impressive efficacy in the PURPOSE-1 PrEP study, leading ...

Vast Data's Enter the Cosmos event on Oct. 1 explores innovation in AI cloud services. Join us for insights on new data ...

Genesis AI Corp. (CSE: AIG) (OTCQB: AIGFF) (the “Company”) is excited to announce the launch of Wildfire Defence Solutions ...